Table 1.
Clinical, analytical and hepatic haemodynamic characteristics of patients with AH included in the Kinase analysis (n=12)
| Variables | Mean±SE or % |
|---|---|
| Age (years) | 49±1.12 |
| Male (%) | 65 |
| Alcohol intake (g/day) | 107.25±4.86 |
| 90-day mortality (%) | 16 |
| Severe AH (by Maddrey DF) (%) | 72 |
| Analytical and haemodynamic parameters | |
| Glucose (mg/dL) | 111±5 |
| Creatinine (mg/dL) | 0.84±0.06 |
| AST (U/L) | 155±12 |
| ALT (U/L) | 61±5 |
| GGT (U/L) | 600±83 |
| Bilirubin (mg/dL) | 12.5±1.21 |
| Albumin (mg/dL) | 26.2±0.55 |
| Platelet count (×109) | 139±14 |
| Leucocyte count (×109/L) | 10.04±7.43 |
| Neutrophils count (%) | 74±8.32 |
| INR | 1.92±0.12 |
| HVPG (mm Hg) | 19.35±0.85 |
| Cirrhosis (%) | 60 |
| Scoring systems | |
| Maddrey’s DF | 59.24±5.97 |
| MELD score | 22±0.8 |
| ABIC score | 7.65±0.19 |
ABIC, age, serum bilirrubin, INR and serum creatinine score; AH, alcoholic hepatitis; ALT, alanine transaminase; AST, aspartate transaminase; GGT, γ-glutamyl transpeptidase; HVPG, hepatic venous pressure gradient; INR, international normalised ratio; MELD, model of end-stage liver disease score.